®®®® SIIA Público

Título del libro: Inflammatory Breast Cancer
Título del capítulo: Recurrent inflammatory breast carcinoma: Prevalence, patterns of recurrence, and therapeutic approach

Autores UNAM:
LUIS ALONSO HERRERA MONTALVO;
Autores externos:

Idioma:
Inglés
Año de publicación:
2013
Resumen:

At present, between 80 and 90 % of cases affected by inflammatory breast cancer (IBC) are treated with multimodal therapy. Neoadjuvant chemotherapy (CT) schemes are mainly comprised of anthracyclines and/or taxanes. Recurrent disease has a prevalence of 70 % and the majority of cases are detected prior to 2 years from the end of multimodal therapy; the recurrence of inflammatory carcinoma can manifest at the locoregional, systemic, or central nervous system (CNS) level; these data can be considered on evaluating the therapeutic options of recurrent inflammatory carcinoma. In this chapter, we approach the behavioral characteristics and therapeutic options of recurrent disease in terms of the recurrence patterns identified. © 2013 Springer-Verlag London.


Entidades citadas de la UNAM: